Growth Metrics

Stemtech (STEK) Equity Average (2020 - 2025)

Stemtech (STEK) has disclosed Equity Average for 6 consecutive years, with -$6.1 million as the latest value for Q3 2025.

  • Quarterly Equity Average changed N/A to -$6.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$6.1 million through Sep 2025, changed N/A year-over-year, with the annual reading at -$4.0 million for FY2024, 34.53% down from the prior year.
  • Equity Average hit -$6.1 million in Q3 2025 for Stemtech, down from -$5.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.1 million in Q1 2021 to a low of -$16.7 million in Q3 2022.
  • Historically, Equity Average has averaged -$5.0 million across 5 years, with a median of -$4.2 million in 2023.
  • Biggest five-year swings in Equity Average: plummeted 5250.53% in 2022 and later soared 86.12% in 2023.
  • Year by year, Equity Average stood at -$4.2 million in 2021, then rose by 6.52% to -$3.9 million in 2022, then skyrocketed by 52.64% to -$1.9 million in 2023, then plummeted by 150.95% to -$4.7 million in 2024, then crashed by 30.7% to -$6.1 million in 2025.
  • Business Quant data shows Equity Average for STEK at -$6.1 million in Q3 2025, -$5.7 million in Q2 2025, and -$5.5 million in Q1 2025.